Delivery Order SPE2DB22D3016-SPE2DB25FBJP7
- Not listed
- The Defense Logistics Agency awarded a $2,518.74 delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with an ultimate completion date of September 2, 2025. This competitive award, priced on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- This delivery order for enoxaparin syringes was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation on October 18, 2023 for a potential value of four US dollars. Performance will take place in Conshohocken, Pennsylvania, with completion by October 19, 2023. The firm fixed price contract was awarded using no set-aside designation to supply the specified pharmaceutical product to the agency. As the Defense Logistics Agency manages the global supply chain for the US...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Enoxaparin 80 mg/0.8 mL syringes, a critical care medication. The contract has a ceiling value of $1,032.12 and an ultimate completion date of September 11, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds several...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,215,870 units of the drug Enoxaparin 40 mg/0.4 ml syringe. The contract has a firm fixed price of $1,204.92 and an ultimate completion date of January 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,186.72, is for the delivery of Enoxaparin 80 mg/0.8 ml syringes. This is a firm-fixed-price delivery order with a completion date of January 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-two thousand four hundred eighty dollars to Amerisourcebergen Drug Corporation for the supply of forty milligrams per four-tenths milliliter enoxaparin syringes. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August seventeenth through eighteenth of twenty twenty-three. The prime contractor, Amerisourcebergen Drug Corporation, is a division of...
- The Defense Logistics Agency awarded a $16,622.35 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This firm fixed-price, non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ1X6, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565713260 - ENOXAPARIN 40 MG/0.4 ML SYR 0.4ML, with a ceiling value of $3,603.84 and a completion date of September 9, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant...
- The Defense Logistics Agency Troop Support Medical awarded a $134,360 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg/ml enoxaparin syringes. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 21-22, 2023. DLA Troop Support Medical utilizes contracts like this to efficiently procure pharmaceuticals and medical supplies in direct support of military treatment facilities and deployed forces worldwide....
- The Defense Logistics Agency awarded a delivery order valued at $9,806.98 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract was executed on September 16, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJP7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enoxaparin 100 mg/ml syringes valued at $2,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain, covering a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Through its competitive contract awards and demonstrated capability to fulfill federal medical supply requirements, AmerisourceBergen continues to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems in meeting critical pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/16/25 |